In this study, it was confirmed that the neurons in the CA1 and CA3 regions, which were reduced in the Aβ-induced AD model, increased significantly in the EPO-treated mice to a level similar to that of the normal control group (Figure 6). The gene discussed is EPO; the disease is Alzheimer disease.